ArticlePLoS computational biology2026
CellPredX, a computational framework for cross-data type, cross-sample, and cross-protocol cell type annotation through domain adaptation and deep metric learning.
Article in PLoS computational biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Reference-guided pseudotime inference across species and biological contexts.bioRxiv : the preprint server for biology · 2026Article
- Topology-guided dual-masked contrastive learning for weakly supervised cell-type annotation in single-cell multi-omics.Briefings in bioinformatics · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Accurate cell type annotation is fundamental to single-cell analysis, yet remains challenging across heterogeneous datasets and modalities. In particular, transferring labels between scRNA-seq and scATAC-seq data poses unique difficulties due to discrepancies in sequencing protocols and feature spaces. Existing methods typically handle only a subset of these challenges, often requiring scenario-specific adjustments and offering limited interpretability. Here, we present CellPredX, a structurally unified but adaptively parameterized, semi-supervised cross-modality framework for label transfer across scRNA-seq, scATAC-seq, and cross-protocol datasets. While maintaining a unified model architecture and optimization strategy, CellPredX allows adaptive tuning of loss-weight hyperparameters to account for the varying degree of similarity or discrepancy between different reference-query dataset pairs. CellPredX integrates domain adaptation and deep metric learning to align heterogeneous embeddings, and introduces a sparse center loss with an attention mechanism to enhance discriminative representations while suppressing noise. Moreover, an integrated interpreter module based on gradient attribution enables biological interpretability by identifying key markers and feature dimensions driving model predictions. Through extensive benchmarking across scRNA to scATAC, scATAC to scATAC, and scRNA to scRNA transfers, CellPredX consistently outperforms state-of-the-art annotation methods in both accuracy and robustness. The interpreter module further reveals biologically meaningful marker patterns that are consistent with known cell hierarchies. Together, these results demonstrate that CellPredX provides an interpretable and scalable solution for cross-modality cell type annotation in single-cell multi-omic integration.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.